| 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on … CT January, LS Wann, JS Alpert, H Calkins, JE Cigarroa, JC Cleveland, ... Journal of the American College of Cardiology 64 (21), e1-e76, 2014 | 9911* | 2014 |
| 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on … RA Nishimura, CM Otto, RO Bonow, BA Carabello, JP Erwin III, ... Circulation 129 (23), e521-e643, 2014 | 9356* | 2014 |
| 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on … MD Jensen, DH Ryan, CM Apovian, JD Ard, AG Comuzzie, KA Donato, ... Circulation 129 (25_suppl_2), S102-S138, 2014 | 5393 | 2014 |
| 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice … RH Eckel, JM Jakicic, JD Ard, JM de Jesus, NH Miller, VS Hubbard, ... Circulation 129 (25_suppl_2), S76-S99, 2014 | 3599 | 2014 |
| Management of patients with peripheral artery disease (compilation of 2005 and 2011 accf/aha guideline recommendations) a report of the american college of cardiology … JL Anderson, JL Halperin, NM Albert, B Bozkurt, RG Brindis, LH Curtis, ... Circulation 127 (13), 1425-1443, 2013 | 964 | 2013 |
| Mitochondria and neuronal activity O Kann, R Kovács American Journal of Physiology-Cell Physiology 292 (2), C641-C657, 2007 | 910 | 2007 |
| 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: a … Writing Committee, DM Lloyd-Jones, PB Morris, CM Ballantyne, ... Journal of the American College of Cardiology 68 (1), 92-125, 2016 | 729* | 2016 |
| Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity DR Witcher, RJ Kovacs, H Schulman, DC Cefali, LR Jones Journal of Biological Chemistry 266 (17), 11144-11152, 1991 | 602 | 1991 |
| Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations) a report of the American College of Cardiology/American … JL Anderson, JL Halperin, NM Albert, B Bozkurt, RG Brindis, LH Curtis, ... Circulation 127 (18), 1916-1926, 2013 | 470 | 2013 |
| Development and validation of a risk score to predict QT interval prolongation in hospitalized patients JE Tisdale, HA Jaynes, JR Kingery, NA Mourad, TN Trujillo, ... Circulation: Cardiovascular Quality and Outcomes 6 (4), 479-487, 2013 | 424 | 2013 |
| Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry CJ Daniels, S Rajpal, JT Greenshields, GL Rosenthal, EH Chung, ... JAMA cardiology 6 (9), 1078-1087, 2021 | 325 | 2021 |
| Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 1: classification of sports: dynamic, static, and impact … BD Levine, AL Baggish, RJ Kovacs, MS Link, MS Maron, JH Mitchell Circulation 132 (22), e262-e266, 2015 | 294 | 2015 |
| Joint HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19 B Bozkurt, R Kovacs, B Harrington Journal of cardiac failure 26 (5), 370, 2020 | 291 | 2020 |
| Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: preamble, principles, and general considerations: a scientific … BJ Maron, DP Zipes, RJ Kovacs Circulation 132 (22), e256-e261, 2015 | 285 | 2015 |
| American Heart Association Task Force on Practice G. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a … NJ Stone, JG Robinson, AH Lichtenstein, CN Bairey Merz, CB Blum, ... Circulation 129 (25 Suppl 2), S1-45, 2014 | 274* | 2014 |
| Surgery for aortic dilatation in patients with bicuspid aortic valves: a statement of clarification from the American College of Cardiology/American Heart Association Task … 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM GUIDELINES FOR THE DIAGNOSIS ... Circulation 133 (7), 680-686, 2016 | 271 | 2016 |
| Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 2: preparticipation screening for cardiovascular disease … BJ Maron, BD Levine, RL Washington, AL Baggish, RJ Kovacs, MS Maron Circulation 132 (22), e267-e272, 2015 | 259 | 2015 |
| Usefulness of fragmented QRS on a 12-lead electrocardiogram in acute coronary syndrome for predicting mortality MK Das, MA Michael, H Suradi, J Peng, A Sinha, C Shen, J Mahenthiran, ... The American journal of cardiology 104 (12), 1631-1637, 2009 | 256 | 2009 |
| Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 10: the cardiac channelopathies: a scientific statement … MJ Ackerman, DP Zipes, RJ Kovacs, BJ Maron Circulation 132 (22), e326-e329, 2015 | 221 | 2015 |
| Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 4: congenital heart disease: a scientific statement from … GF Van Hare, MJ Ackerman, JK Evangelista, RJ Kovacs, RJ Myerburg, ... Circulation 132 (22), e281-e291, 2015 | 220 | 2015 |
